首页 > 市场调查报告书 > 製药

精神疾病

市场调查报告书

商品编码

1741531

全球恐慌症治疗市场按药物类别、给药途径、分销管道和地区划分

Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

恐慌症治疗市场规模预计在 2025 年达到 29.2 亿美元，预计到 2032 年将达到 86.6 亿美元，2025 年至 2032 年的复合年增长率为 16.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	29.2亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	16.80%	2032年价值预测	86.6亿美元

惊恐发作是指突然发生的强烈恐惧和痛苦，可能会使患者虚弱无力。这些发作通常毫无征兆，并可能引起心悸、呼吸急促和胸痛等身体症状。恐慌发作的治疗着重于缓解症状、减少发作频率并改善整体生活品质。

市场动态：

预计恐慌症治疗市场将在未来几年内实现显着成长。全球市场受多种因素驱动，其中包括全球范围内恐慌症盛行率的上升。心理健康意识的提升以及对恐慌症的接受度和理解度的提高也促进了市场的成长。此外，医疗技术和治疗性介入的进步也推动了更有效的恐慌症治疗方法的发展。

然而，也有一些因素限制着市场的成长。该市场面临的主要挑战之一是与心理健康问题（包括恐慌症）相关的污名化。这种污名化常常阻碍人们寻求帮助和治疗。此外，治疗恐慌症的高昂费用以及某些地区较差的报销政策也构成了市场成长的潜在障碍。

儘管面临诸多挑战，市场仍存在着许多机会。人们对能够有效控制恐慌发作的个人化和标靶治疗的需求日益增长。此外，虚拟实境技术与人工智慧在恐慌发作治疗中的融合有望为市场扩张开闢新的途径。此外，製药业主主要企业加大对研发活动的投入，可能会推动该市场的技术创新，创造成长机会。

本研究的主要特点

本报告对全球恐慌症治疗市场进行了详细分析，包括预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势和驱动因素、区域前景以及主要企业采用的竞争策略的主要考察。
本报告的见解将使负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
全球恐慌症治疗市场报告迎合了各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和行业财务分析师。
相关人员可以从用于分析全球恐慌症治疗市场的各种策略矩阵中受益，从而促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2.92 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.80%	2032 Value Projection:	USD 8.66 Bn

Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.

Market Dynamics:

The Panic Attack Treatment market is expected to witness significant growth in the coming years. The global market is driven by several factors, including the increasing prevalence of panic disorders worldwide. The rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, is also contributing to market growth. Additionally, advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks.

However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues, including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to market growth.

Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Additionally, the increasing investments in research and development activities by key players in the pharmaceutical industry are likely to drive innovation in this market and create growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global Panic Attack Treatment market, including market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Key players in the global Panic Attack Treatment market, such as GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S, are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies.
Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
The global Panic Attack Treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry.
Stakeholders can benefit from various strategy matrices used in analyzing the global Panic Attack Treatment market, which would facilitate ease in decision-making.

Global Panic Attack Treatment Market Segmentation:

By Drug Class
- Antidepressants
- SSRIs
- SNRIs
- TCAs
- MAOIs
- Others
- Anti-anxiety Drugs
- Benzodiazepines
- Beta Blockers
- CGRP Antagonists
- Others
By Route of Administration
- Oral
- Intravenous
- Intramuscular
- Sublingual
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- GlaxoSmithKline plc
- F.Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of anxiety and panic disorders
- Restraints
Side effects and safety issues with medications
- Opportunities
Growing use of telemedicine and e-therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Panic Attack Treatment Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anti-anxiety Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
CGRP Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lundbeck A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球恐慌症治疗市场按药物类别、给药途径、分销管道和地区划分

Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

市场动态：

本研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 全球恐慌症治疗市场-冠状病毒（COVID-19）大流行的影响

5. 2020 年至 2032 年全球恐慌症治疗市场（依药物类别）

6. 2020 年至 2032 年按给药途径分類的全球恐慌症治疗市场

7. 2020 年至 2032 年全球恐慌症治疗市场（依通路划分）

8. 2020 年至 2032 年全球恐慌症治疗市场（按地区）

第九章竞争态势

第 10 章章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Panic Attack Treatment Market, By Drug Class, 2020-2032, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

全球恐慌症治疗市场按药物类别、给药途径、分销管道和地区划分

Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

市场动态：

本研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 全球恐慌症治疗市场-冠状病毒（COVID-19）大流行的影响

5. 2020 年至 2032 年全球恐慌症治疗市场（依药物类别）

6. 2020 年至 2032 年按给药途径分類的全球恐慌症治疗市场

7. 2020 年至 2032 年全球恐慌症治疗市场（依通路划分）

8. 2020 年至 2032 年全球恐慌症治疗市场（按地区）

第九章 竞争态势

第 10 章 章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Panic Attack Treatment Market, By Drug Class, 2020-2032, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第一章调查目的与前提条件

第二章市场展望

第九章竞争态势

第 10 章章节